A full-service solution for clinical trial packaging and distribution, Myonex will help you find the best packaging, labeling, and distribution solution for your trial.
Myonex facilities in the U.S., the United Kingdom, Germany, and Denmark offer a wide range of clinical trial packaging and labeling services to meet your specific needs. We are experts at storing, packaging, labeling, and shipping investigational and commercial medicine. We strive to offer tailored solutions that save you time and give you flexibility if your packaging and labeling needs change suddenly.
Whether your clinical trial needs open-label, blinded, or expiry extensions in GMP packaging (production), or just-in-time (JIT), Myonex prioritizes…
Our global logistics team will get your product shipped to sites on time, as well as handle returns of unused inventory. Myonex also has many years of experience with the especially complex packaging, labeling, and distribution needs of oncology clinical trials.
A full-service solution for clinical trial packaging, labeling, and distribution, Myonex will help you find the best packaging, labeling, and distribution services for your trial.
Contact your Myonex representative or email [email protected] to discuss how Myonex can support your packaging, labeling, and distribution needs for your next global clinical trial.
Study startup in days, not weeks
Batch record generation completed in less than a week
US JIT labeling same day as shipping request received
EU Batch labeling ready to go with no long queue
“We were in a tight situation and Myonex got us the product we needed, with the distribution documentation and full labeling instructions, in two days. They labeled the drug, shipped it and got it to our sites the next morning. I don’t know of anyone else in the business who could have pulled that off.”Clinical Operations Manager
“We once had to switch from standard commercial packs to custom labeling in the middle of a study. Myonex was able to get us local market stock while they put the new labeling scheme in place. It was complicated, because we had sites in a dozen different regions, but we never missed a single patient dose.”Clinical Trial Supply Manager